摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-氯-2-巯基苯并恶唑 | 22876-20-6

中文名称
6-氯-2-巯基苯并恶唑
中文别名
2-巯基-6-氯苯并恶唑
英文名称
6-chlorobenzo[d]oxazole-2-thiol
英文别名
2-mercapto-6-chlorobenzoxazole;6-chloro-2-mercaptobenzoxazole;6-chloro-2-benzoxazolethiol;6-chloro-benzooxazole-2-thiol;6-chloro-3H-1,3-benzoxazole-2-thione
6-氯-2-巯基苯并恶唑化学式
CAS
22876-20-6
化学式
C7H4ClNOS
mdl
MFCD00800495
分子量
185.634
InChiKey
HAASPZUBSZGCKU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    229-232 °C
  • 沸点:
    288.9±42.0 °C(Predicted)
  • 密度:
    1.2291 (rough estimate)
  • 稳定性/保质期:
    <p>遵照规定使用和储存,则不会分解。</p>

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    53.4
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 安全说明:
    S24/25
  • 海关编码:
    2934999090
  • 危险性防范说明:
    P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:7cb372651bd892bfadef4b0f1374f80b
查看
Name: 6-Chloro-2-benzoxazolethiol 99% Material Safety Data Sheet
Synonym:
CAS: 22876-20-6
Section 1 - Chemical Product MSDS Name:6-Chloro-2-benzoxazolethiol 99% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
22876-20-6 6-Chloro-2-benzoxazolethiol 99 245-282-8
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam. Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 22876-20-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 201 - 204 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H4ClNOS
Molecular Weight: 185.63

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 22876-20-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
6-Chloro-2-benzoxazolethiol - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 22876-20-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 22876-20-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 22876-20-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    苯并噻唑尿素是17β-HSD10的低微摩尔和非竞争性抑制剂,与阿尔茨海默氏病的治疗有关
    摘要:
    人17β-羟类固醇脱氢酶10型是一种多功能蛋白,参与线粒体内的许多酶和结构过程。该酶被认为与几种神经系统疾病有关,例如智力低下,帕金森氏病或阿尔茨海默氏病,其中该酶与淀粉样β肽相互作用。我们基于苯并噻唑基支架制备了约60种新化合物,并评估了它们的抑制能力和作用机理。最有效的抑制剂在苯环部分包含3-氯和4-羟基取代基,在苯并噻唑部分的6位上具有小的取代基,并且两个部分通过脲连接基连接(4at,4bb和4bg)。这些化合物的IC50值为1-2μM,对底物乙酰乙酰辅酶A表现出无竞争性的作用机理。这些17β-羟基类固醇脱氢酶的非竞争性苯并噻唑基抑制剂是有希望用于神经退行性疾病潜在药物的化合物,值得进一步研究和开发。
    DOI:
    10.3390/ijms21062059
  • 作为产物:
    描述:
    2-苯并唑啉酮三氯异氰尿酸 、 sodium hydroxide 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 1.17h, 生成 6-氯-2-巯基苯并恶唑
    参考文献:
    名称:
    以固体三光气为氯化剂从邻氨基苯酚制备2-氯苯并噁唑和2,6-二氯苯并噁唑的方法
    摘要:
    本发明提供了一种以固体三光气为氯化剂从邻氨基苯酚制备2‑氯苯并噁唑和2,6‑二氯苯并噁唑的方法,包括:步骤1,以邻氨基苯酚为原料分别制备2‑苯并噁唑酮和2‑巯基苯并噁唑;步骤2,以2‑巯基苯并噁唑为原料、以固体三光气为氯化剂制备2‑氯苯并噁唑;步骤3,以TCCA和2‑苯并噁唑酮为原料制备6‑氯苯并噁唑酮;步骤4,制备2‑巯基‑6‑氯苯并噁唑;步骤5,以2‑巯基‑6‑氯苯并噁唑为原料,以固体三光气为氯化剂,制备2,6‑二氯苯并噁唑。本发明是一种全新的制备方法,对设备腐蚀小,产率高,反应时间少,反应条件温和,副产物少,减小了环境污染。
    公开号:
    CN108794421A
点击查看最新优质反应信息

文献信息

  • [EN] ANTIBIOTIC COMPOUNDS<br/>[FR] COMPOSÉS ANTIBIOTIQUES
    申请人:DISCUVA LTD
    公开号:WO2018037223A1
    公开(公告)日:2018-03-01
    The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.
    本发明涉及公式(I)的抗生素化合物,含有这些化合物的组合物,以及使用这些化合物治疗细菌性疾病和感染的方法。这些化合物在治疗革兰氏阳性和/或革兰氏阴性细菌引起的感染和疾病方面具有应用,特别是在治疗由淋病奈瑟菌引起的感染和疾病方面。
  • [EN] DIAZEPANE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR<br/>[FR] COMPOSÉS DE DIAZÉPANE QUI MODULENT LE RÉCEPTEUR CB2
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2009055357A1
    公开(公告)日:2009-04-30
    Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
    公开了公式(I)的化合物。根据发明的化合物能够结合并成为CB2受体的激动剂、拮抗剂或反向激动剂,并且用于治疗炎症。其中作为激动剂的化合物还可额外用于治疗疼痛。
  • An environmentally benign and efficient synthesis of substituted benzothiazole-2-thiols, benzoxazole-2-thiols, and benzimidazoline-2-thiones in water
    作者:Xing Liu、Min Liu、Wan Xu、Meng-Tian Zeng、Hui Zhu、Cai-Zhu Chang、Zhi-Bing Dong
    DOI:10.1039/c7gc02311a
    日期:——
    An efficient and practical method for the one-step synthesis of benzothiazole-2-thiols, benzoxazole-2-thiols and benzimidazoline-2-thiones by cyclization of 2-aminothiophenols, 2-aminophenols, and 1,2-phenylenediamines with tetramethylthiuram disulfide (TMTD) in water was described. The features of this method include metal/ligand-free, excellent yield, short reaction time and broad substrate scope
    一种有效而实用的方法,是通过将2-氨基硫酚,2-氨基酚和1,2-苯二胺与四甲基秋兰姆二硫化物环化,一步一步合成苯并噻唑-2-硫醇,苯并恶唑-2-硫醇和苯并咪唑啉-2-硫酮(描述了在水中的TMTD。该方法的特点包括无金属/配体,优异的产率,较短的反应时间和广泛的底物范围。该方法提供了一些潜在的生物活性化合物的简便的制备方法。
  • Selective synthesis of 2-aminobenzoxazoles and 2-mercaptobenzoxazoles by using o-aminophenols as starting material
    作者:Min Liu、Meng-Tian Zeng、Wan Xu、Li Wu、Zhi-Bing Dong
    DOI:10.1016/j.tetlet.2017.09.092
    日期:2017.11
    dithiocarbamates and tetramethylthiuram disulfide (TMTD), respectively. With the promotion of NaH/CuI, the reaction of o-aminophenols with dithiocarbamates gave 2-aminobenzoxazoles with good yield (70–92%) in one pot manner, and 2-mercaptobenzoxazoles were synthesized (yield: 55–80%) in the presence of K2CO3 by treating o-aminophenols with tetramethylthiuram disulfide (TMTD). The feature of this method
    通过分别用二硫代氨基甲酸酯和四甲基秋兰姆二硫化物(TMTD)处理邻氨基苯酚来选择性合成2-氨基苯并恶唑和2-巯基苯并恶唑。随着NaH / CuI的促进,邻氨基苯酚与二硫代氨基甲酸酯的反应可以一锅法得到2-氨基苯并恶唑,收率良好(70-92%),而合成2-巯基苯并恶唑(收率:55-80%)。通过用二甲基四甲基秋兰姆(TMTD)处理邻氨基苯酚来获得K 2 CO 3的存在。该方法的特征包括良好到极好的收率,容易的操作和广泛的底物范围,这使得该方案在制备某些潜在的药物活性化合物中具有实用性和吸引力。
  • Disulfide Bond-Containing Ajoene Analogues As Novel Quorum Sensing Inhibitors of <i>Pseudomonas aeruginosa</i>
    作者:July Fong、Mingjun Yuan、Tim Holm Jakobsen、Kim T. Mortensen、May Margarette Salido Delos Santos、Song Lin Chua、Liang Yang、Choon Hong Tan、Thomas E. Nielsen、Michael Givskov
    DOI:10.1021/acs.jmedchem.6b01025
    日期:2017.1.12
    Since its discovery 22 years ago, the bacterial cell-to-cell communication system, termed quorum sensing (QS), has shown potential as antipathogenic target. Previous studies reported that ajoene from garlic inhibits QS in opportunistic human pathogen Pseudomonas aeruginosa. In this study, screening of an in-house compound library revealed two sulfur-containing compounds which possess structural resemblance
    自22年前被发现以来,被称为群体感应(QS)的细菌细胞间通讯系统已显示出潜在的抗病原性靶标。先前的研究报道大蒜中的阿jo烯抑制机会性人类病原体铜绿假单胞菌的QS 。在这项研究中,通过对内部化合物库的筛选,发现了两种含硫化合物,它们与阿霍烯具有相似的结构,并在生物报告检测中抑制了QS。经过定量结构-活性关系(SAR)研究,合成了25个含二硫键的类似物,并测试了其QS抑制活性。SAR研究表明,烯丙基可以被其他取代基取代,最活跃的是苯并噻唑衍生物(IC 50= 0.56μM)。这些化合物能够降低QS调节的毒力因子(弹性蛋白酶,鼠李糖脂和绿脓素),并在与植入物相关的感染的小鼠模型中成功抑制铜绿假单胞菌的感染。总之,合成化合物的QS抑制活性令人鼓舞,以进一步探索抗菌药物开发中的新类似物。
查看更多

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯 氯唑沙宗-2-13C-3-15N-羟基-18O 氯唑沙宗 氯化3-乙基-2-[2-(1-乙基-2,5-二甲基-1H-吡咯-3-基)乙烯基]苯并恶唑翁盐 昂唑司特 拂来星-d2